Both in Biotechnology
Dyadic International vs TScan Therapeutics
Over the past year DYAI returned −66.7% and TCRX returned −84.8%; their daily moves had a correlation of 0.11.
DYAI −66.7% TCRX −84.8%Growth of $1, one year, split-adjusted
| Metric | DYAI | TCRX |
|---|---|---|
| Price | $0.3600 | $0.1890 |
| Market cap | $14.4M | $12.8M |
| Today | −4.26% | +5.47% |
| 1 month | −20.7% | −36.0% |
| 6 months | −53.3% | −84.4% |
| Year to date | −61.7% | −81.1% |
| 1 year | −68.1% | −90.3% |
| Revenue growth (YoY) | −0.6% | −65.8% |
| Gross margin | −2.4% | 100.0% |
| Net margin | −221.0% | −2888.6% |
| P/E (TTM) | — | — |
| Price / sales | 3.8× | 1.8× |
| Net cash | -$1.9M | $67.4M |
| Dividend yield | — | — |
| Volatility (60d) | 77.8% | 140.8% |
| Short % of float | 0.7% | 4.1% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).